Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
---|
06/25/2009 | CA2708866A1 Bicyclic heterocyclic derivative |
06/25/2009 | CA2708324A1 Viral polymerase inhibitors |
06/25/2009 | CA2707785A1 Indoles and their therapeutic use |
06/25/2009 | CA2706839A1 Aminotriazole derivatives as alx agonists |
06/25/2009 | CA2706837A1 5-aminocyclylmethyl-oxazolidin-2-one derivatives |
06/24/2009 | EP1737881B1 Novel compounds as inhibitors of hepatitis c virus ns3 serine protease |
06/24/2009 | EP1445258B1 Activator for peroxisome proliferator-activated receptor delta |
06/24/2009 | EP1339709B1 Farnesyl transferase inhibiting benzoheterocyclic derivatives |
06/24/2009 | CN101466710A Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
06/24/2009 | CN101463031A Indazole and tetrahydrochysene indazole compounds, and preparation, pharmaceutical composition and use thereof |
06/24/2009 | CN100503606C Thiadiazoles substituted imidazoles anti-anaerobe compounds |
06/24/2009 | CN100503604C Iminobenzoxazines, iminobenzthiazines and iminoquinazolines for controlling invertebrate pests |
06/24/2009 | CN100503600C Pesticidal heterocycles |
06/24/2009 | CN100503589C Sulphona mide derivatives as prodrugs of aspartyl protease inhibitors |
06/24/2009 | CN100503576C Substituted azole compounds, preparation and application thereof |
06/24/2009 | CN100503566C Inhibitors of cytosolic phospholipase A2 |
06/24/2009 | CN100502863C 2,4,5-trisubstituded thiazolyl derivatives and their anti-inflammatory activity |
06/23/2009 | USRE40793 treating conditions related to impairment of gastric emptying, gastromotility disorders; superior gastrokinetic properties; e.g. trans-4-amino-N-[(1-butyl-3-hydroxy-4-piperidinyl)methyl]-5-chloro-2,3-dihydro-7-benzofurancarboxamide |
06/23/2009 | US7550624 For treating or inhibiting increased urinary urgency or urinary incontinence and/or pain |
06/23/2009 | US7550590 Such as 2-[2-(3-Amino-piperidin-1-yl)4-oxo-4H-quinazolin-3-ylmethyl]-benzonitrile; type 2 diabetes mellitus, diabetic dislipidemia, impaired glucose tolerance |
06/23/2009 | US7550499 Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions |
06/23/2009 | US7550492 Cholecystokinin (CCK2) receptor modulators; e.g. 2-(Benzo[1,2,5]thiadiazole-4sulfonylamino)-4-fluoro-N-[1-(4-fluoro-phenyl)-ethyl]-N-methyl-benzamide; pancreatic adenocarcinoma, pain, eating disorders, gastro-esophageal reflux disease, ulcers, anxiety |
06/23/2009 | US7550487 Factor Xa inhibitors; anticoagulants; thrombotic disorders; (3R,4R)-3-(4-Chloro-phenylcarbamoyl)-4-[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-pyrrolidine-1-carboxylic acid propyl ester for example |
06/23/2009 | US7550486 chemokine receptor (CCR) inhibitors for treating allergic or inflammatory diseases such as asthma or rheumatoid arthritis, multiple sclerosis, inflammatory bowel diseases; 2-((p-fluorobenzyl)piperidinylmethyl)cyclohexylureas of given formula |
06/23/2009 | US7550484 Elevate the progenitor and/or stem cell population in peripheral blood or bone marrow; treatment of HIV, inflammatory condition like rheumatoid arthritis, tumor, asthma; 4-(3,3''-Dimethyl-3',4',5',6'-tetrahydro-2'H-cis-[2,2';6',2'']terpyridin-1'-yl-butylamine |
06/23/2009 | US7550469 Heterocyclic amide derivatives and their use as dopamine D3 receptor ligands |
06/23/2009 | US7550463 Carbamoylpyridone derivatives having inhibitory activity against HIV integrase |
06/23/2009 | US7550461 Benzofuran and benzothiophene compounds useful in treating cytokine mediated diseases |
06/23/2009 | US7550460 2,4-pyrimidinediamine compounds and their uses |
06/23/2009 | US7550459 Neurodegenerative diseases, psychological disorders; e.g. 4-[3-(3a -Cyclopropylmethoxy-8-azabicyclo[3.2.1]oct-8-yl)-2-methylpropyl]-4H-benzo[1.4]oxazin-3-one |
06/23/2009 | US7550424 aromatic and heterocyclic sulfonamides, to treat preneoplastic and/or neoplastic diseases by specifically inhibiting the carbonic anhydrase activity of the oncoprotein now known alternatively as the MN protein, the MN/CA IX isoenzyme |
06/23/2009 | CA2522220C Cgrp receptor antagonists |
06/23/2009 | CA2504735C Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
06/23/2009 | CA2449874C New indole derivatives with 5-ht6 receptor affinity |
06/23/2009 | CA2384354C Pyrimidine derivatives and herbicides containing them |
06/18/2009 | WO2009076502A1 Methods for the preparation of hydroxy-substituted aryl sulfamide compounds |
06/18/2009 | WO2009075691A1 Cb-1 modulating compounds and their use |
06/18/2009 | WO2009075250A1 Plant disease control agent |
06/18/2009 | WO2009074829A1 Peptidyl nitriles and use thereof as dipeptidyl peptidase i inhibitors |
06/18/2009 | WO2009074812A1 Antibacterial condensed thiazoles |
06/18/2009 | WO2009074605A1 Aminothiazoles and their uses |
06/18/2009 | WO2009074247A1 Novel 2-aryl-thiazole-4-carboxamide derivatives, production thereof, and use thereof as a medicament |
06/18/2009 | WO2009074246A1 Novel 2-hetaryl thiazole-4-carboxamide derivatives, production thereof, and use thereof as a medicament |
06/18/2009 | WO2009074234A1 Novel 2-substituted thiazole-4-carboxamide derivatives, production thereof, and use thereof as a medicament |
06/18/2009 | WO2009074231A2 Insecticidal imino heterocycles |
06/18/2009 | WO2009074019A1 Proteinase inhibitors useful for treating cancer |
06/18/2009 | WO2009046841A3 Piperidine and piperazine derivatives for treating tumours |
06/18/2009 | WO2009036996A3 Small molecule bradykinin b1 receptor antagonists |
06/18/2009 | WO2008072053A8 Substituted arylpyrazoles |
06/18/2009 | WO2007124337A8 Biphenyl amide lactam derivatives as inhibitors of 11- beta-hydroxysteroid dehydrogenase 1 |
06/18/2009 | WO2007027532A3 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
06/18/2009 | US20090158019 Computer Program Code Size Partitioning System for Multiple Memory Multi-Processing Systems |
06/18/2009 | US20090156826 Methods for the preparation of hydroxy-substituted aryl sulfamide compounds |
06/18/2009 | US20090156805 Cycloalkane Carboxamide Derivatives and Production Process of Same |
06/18/2009 | US20090156802 Quetiapine Hemifumarate Purification by Crystallization |
06/18/2009 | US20090156644 Use of thiazole derivatives and analogues in the treatment of cancer |
06/18/2009 | US20090156622 2,4-pyrimidinediamine compounds and their uses |
06/18/2009 | US20090156608 Pyridazine Compound and Use Thereof |
06/18/2009 | US20090156603 2-aminopyridine analogs as glucokinase activators |
06/18/2009 | US20090156592 Fungicidal Azocyclic Amides |
06/18/2009 | US20090156591 Thiophene and Thiazole Substituted trifluoroethanone Derivatives as Histone Deacetylase (Hdac) Inhibitors |
06/18/2009 | US20090156589 1,2-di(cyclic group)substituted benzene derivative |
06/18/2009 | US20090156586 Compounds for the treatment of inflammatory disorders |
06/18/2009 | US20090156574 N-(4-(5-Butyl-2-methoxyphenyl)-1,3-thiazol-2-yl)-4-((4-oxopiperidin-1-yl)carbonyl)benzamide; antiinflammatory, anticarcinogenic, antidiabetic, analgesic agents |
06/18/2009 | US20090156572 Nitrogen-containing heterocyclic compound and use thereof |
06/18/2009 | US20090156571 Biphenyl amide lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
06/18/2009 | US20090155203 Thrombopoietin mimetics |
06/18/2009 | US20090152535 Novel materials for improving the hole injection in organic electronic devices and use of the material |
06/18/2009 | CA2709021A1 Antibacterial condensed thiazoles |
06/18/2009 | CA2708793A1 Aminothiazoles and their uses |
06/18/2009 | CA2708150A1 Fluorinated tripeptide hcv serine protease inhibitors |
06/18/2009 | CA2706813A1 Novel 2-arylthiazole-4-carboxamide derivatives, their preparation and use as pharmaceuticals |
06/18/2009 | CA2706811A1 Novel 2-hetarylthiazole-4-carboxamide derivatives, their preparation and use as pharmaceuticals |
06/18/2009 | CA2706806A1 Novel 2-substituted tiazole-4-carboxamide derivatives, their preparation and use as pharmaceuticals |
06/18/2009 | CA2706679A1 Novel compounds 010 |
06/17/2009 | EP2070925A1 New 2-substituted tiazol-4-carboxylic acid derivatives, their manufacture and use as medicine |
06/17/2009 | EP2070924A1 New 2 hetarylthiazol-4-carboxylic acid derivatives, their manufacture and use as medicine |
06/17/2009 | EP2070923A1 Insecticide iminoheterocycles |
06/17/2009 | EP2070922A1 Azabicyclo(3.1.0) hexane derivatives useful as modulators of dopamine D3 receptors |
06/17/2009 | EP2070916A1 2-Arylthiazol-4-carboxylic acid derivatives, their manufacture and use as medicine |
06/17/2009 | EP2070534A2 Cyclopropyl and cyclobutyl epothilone analogs |
06/17/2009 | EP2069336A1 Pyridin-4-yl derivatives as immunomodulating agents |
06/17/2009 | EP2069335A1 Pyridin-3-yl derivatives as immunomodulating agents |
06/17/2009 | EP2069332A2 Azetidine compounds as orexin receptor antagonists |
06/17/2009 | EP2069327A1 New pyridone derivatives with mch antagonistic activity and medicaments comprising these compounds |
06/17/2009 | EP2069326A2 Bicyclic and tricyclic derivatives as thrombin receptor antagonists |
06/17/2009 | EP2069316A1 2,4-diaminoquinazolines for spinal muscular atrophy |
06/17/2009 | EP2069310A2 Sulfonylpyrazoline carboxamidine derivatives as 5-ht6 antagonists |
06/17/2009 | EP2069305A2 Nicotinic acid derivatives as modulators of metabotropic glutamate receptors |
06/17/2009 | EP2068632A1 Fungicides |
06/17/2009 | EP1789419B1 Gyrase inhibitors and uses thereof |
06/17/2009 | EP1773822B1 Heterocyclyls as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders |
06/17/2009 | EP1611088B1 Hydroxamates as therapeutic agents |
06/17/2009 | EP1542990B1 Novel imidazole compounds as transforming growth factor (tgf) inhibitors |
06/17/2009 | EP1485381B1 Azolylaminoazine as inhibitors of protein kinases |
06/17/2009 | EP1472230B1 Ansamycins having improved pharmacological and biological properties |
06/17/2009 | EP1357115B1 Alkanoic acid derivatives, process for their production and use thereof |
06/17/2009 | EP1171428B1 Fab i inhibitors |
06/17/2009 | CN100500663C N-(4-(4-methylthiazol-5-yl) pyrimidin-2-yl) -n-phenylamines as antiproliferative compounds |
06/16/2009 | US7547794 antiproliferative agents; antiinflammatory agents; neurodegenerative agents; autoimmune diseases; viricides |